Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The functional exercise capacity is correlated with global functioning in patients with schizophrenia.
Vancampfort D, Probst M, Scheewe T, Knapen J, De Herdt A, De Hert M.
Acta Psychiatr Scand. 2012 May;125(5):382-7. doi: 10.1111/j.1600-0447.2011.01825.x. Epub 2012 Jan 12.
Related citations
Menstrual exacerbation of schizophrenia symptoms.
Seeman MV.
Acta Psychiatr Scand. 2012 May;125(5):363-71. doi: 10.1111/j.1600-0447.2011.01822.x. Epub 2012 Jan 12.
Error occurred: cannot get document summary
Overexpression of chromosome 15q11-q13 gene products: a risk factor for schizophrenia and associated psychoses?
Boot E, Kant SG, Otter M, Cohen D, Nabanizadeh A, Baas RW.
Am J Psychiatry. 2012 Jan;169(1):96-7; author reply 97. No abstract available.
Are all antipsychotic drugs the same?
Leucht S, Davis JM.
Br J Psychiatry. 2011 Oct;199(4):269-71. doi: 10.1192/bjp.bp.111.095323. No abstract available.
The rise and fall of the atypical antipsychotics.
Kendall T.
Br J Psychiatry. 2011 Oct;199(4):266-8. doi: 10.1192/bjp.bp.110.083766. No abstract available.
Antipsychotics in the treatment of schizophrenia: an overview.
Tandon R.
J Clin Psychiatry. 2011;72 Suppl 1:4-8. Review.
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? a meta-analysis.
Sommer IE, de Witte L, Begemann M, Kahn RS.
J Clin Psychiatry. 2012 Apr;73(4):414-9. Epub 2011 Dec 13.
Interpersonal sensitivity in the at-risk mental state for psychosis.
Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR.
Psychol Med. 2012 Jan 9:1-11. [Epub ahead of print]
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
Corcoran CM, Smith C, McLaughlin D, Auther A, Malaspina D, Cornblatt B.
Schizophr Res. 2012 Mar;135(1-3):170-4. Epub 2012 Jan 9.
Abnormal connectivity between attentional, language and auditory networks in schizophrenia.
Liemburg EJ, Vercammen A, Ter Horst GJ, Curcic-Blake B, Knegtering H, Aleman A.
Schizophr Res. 2012 Mar;135(1-3):15-22. Epub 2012 Jan 9.
Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed.
Ojeda N, Peña J, Schretlen DJ, Sánchez P, Aretouli E, Elizagárate E, Ezcurra J, Gutiérrez M.
Schizophr Res. 2012 Mar;135(1-3):72-8. Epub 2012 Jan 5.
Decreased peripheral expression of neuregulin 1 in high-risk individuals who later converted to psychosis.
Kiss I, Kelemen O, Kéri S.
Schizophr Res. 2012 Mar;135(1-3):198-9. Epub 2012 Jan 9. No abstract available.
Inhibition of return and schizophrenia: a meta-analysis.
Mushquash AR, Fawcett JM, Klein RM.
Schizophr Res. 2012 Mar;135(1-3):55-61. Epub 2012 Jan 4.
Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia.
Zhou FC, Xiang YT, Wang CY, Dickerson F, Au RW, Zhou JJ, Zhou Y, Shum DH, Chiu HF, Man D, Lee EH, Yu X, Chan RC, Ungvari GS.
Schizophr Res. 2012 Mar;135(1-3):34-9. Epub 2012 Jan 4.
Brief Psychiatric Rating Scale - Excited Component (BPRS-EC) and neuropsychological dysfunction predict aggression, suicidality, and involuntary treatment in first-episode psychosis.
Huber CG, Schöttle D, Lambert M, Hottenrott B, Agorastos A, Naber D, Schroeder K.
Schizophr Res. 2012 Feb;134(2-3):273-8. Epub 2012 Jan 4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on